Xingwang Sun
Impact in
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
- Materials Chemistry top 10%
- Luminescence and Fluorescent Materials
- Advanced Nanomaterials in Catalysis
Papers in
-
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- Histone Deacetylase Inhibitors Research 2
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Yuanxue Zhang (2 shared papers)Tiejun Zhou (1 shared paper)Chongwei Chi (1 shared paper)Song Su (1 shared paper)Xiaojing Shi (1 shared paper)Meishan Cai (1 shared paper)Bo Li (1 shared paper)Cheng Fang (1 shared paper)
- Journals
- Virology Journal (2 papers)DNA and Cell Biology (2 papers)Cancer Management and Research (2 papers)Clinical & Translational Oncology (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Xingwang Sun
23 papers receiving 1.1k citations
Xingwang Sun's Hit Papers
Peers
Comparison fields: 5 of 88
- Biomedical Engineering 702
- Materials Chemistry 422
- Cancer Research 121
- Biophysics 42
- Biomaterials 74
Countries citing papers authored by Xingwang Sun
This map shows the geographic impact of Xingwang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwang Sun more than expected).
Fields of papers citing papers by Xingwang Sun
This network shows the impact of papers produced by Xingwang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwang Sun. The network helps show where Xingwang Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingwang Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows Hit paper breakdown → | 2019 | 871 |
| 2 | 2018 | 67 | |
| 3 | 2018 | 54 | |
| 4 | 2013 | 20 | |
| 5 | 2013 | 16 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 8 | |
| 11 | 2017 | 7 | |
| 12 | 2012 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 2 | |
| 20 | [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]. | 2005 | 2 |
About Xingwang Sun
Xingwang Sun is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Cancer-related gene regulation (4 papers), Genetic factors in colorectal cancer (3 papers), Esophageal Cancer Research and Treatment (3 papers), Ferroptosis and cancer prognosis (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Biomedical Engineering (702 citations), Materials Chemistry (422 citations), Cancer Research (121 citations), Biophysics (42 citations) and Biomaterials (74 citations). Xingwang Sun has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yuanxue Zhang, Tiejun Zhou, Chongwei Chi, Song Su, Xiaojing Shi, Meishan Cai, Bo Li, Cheng Fang, Zhen Cheng and Sanjiv S. Gambhir. Their work appears in journals such as Virology Journal, DNA and Cell Biology, Cancer Management and Research, Clinical & Translational Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.